Clinical Trial Update: Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a nucleoside analogue to prevent vertical transmission of Hepatitis B virus has completed. The update notes the completion o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Nucleoside analogue (nucleoside analogue)

Snippet

Sponsor: Hua Zhang | Conditions: Hepatitis B Infection, Chronic Infection | Phase 4 | Status: COMPLETED